Services on Demand
Journal
Article
Indicators
- Cited by SciELO
Related links
- Similars in SciELO
Share
Revista argentina de dermatología
On-line version ISSN 1851-300X
Abstract
MANFRIN, J. et al. Malignant Lentigo treated with imiquimod 5%. Presentation of a case and review of the subject. Rev. argent. dermatol. [online]. 2019, vol.100, n.3, pp.81-92. Epub Sep 30, 2019. ISSN 1851-300X.
Malignant lentigo (LM) is a variant of in situ melanoma that develops mainly in areas of chronic sun exposure in middle-aged patients. Without treatment, 5% to 50% of the LM can progress to a lentigo maligna melanoma (LMM).
Although the treatment of choice is surgical, imiquimod seems to be a viable and non-invasive option in patients with large tumors, elderly or people with underlying disease, or who simply reject the surgical removal of the lesion.
We present a case of LM satisfactorily treated with topical imiquimod.
Keywords : lentigo; malignant; melanoma; imiquimod; immunomodulator.